search
Back to results

EBUS Guided Cryobiopsies With Ultrathin Cryoprobe in Patients With Peripheral Pulmonary Nodules - a Feasibility Study

Primary Purpose

Transbronchial Cryobiopsy

Status
Completed
Phase
Not Applicable
Locations
Germany
Study Type
Interventional
Intervention
EBUS cryo probe
Sponsored by
Thoraxklinik-Heidelberg gGmbH
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Transbronchial Cryobiopsy

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Single or multiple peripheral pulmonary round foci in CT
  • signed patient information

Exclusion Criteria:

  • severe co-mornidity
  • no signed patien information
  • contraindication for intervention

Sites / Locations

  • Thoraxklinik Universitaetsmedizin

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

EBUS cryo probe

Arm Description

Patients receive a transbronchial cryobiopsy using an eBUS cryo probe

Outcomes

Primary Outcome Measures

Feasibility of the procedure - assessed by diagnosis agreement within the multidisciplinary team discussion
Pathological assessment of biopsies for ILD diagnosis

Secondary Outcome Measures

Bleeding time in seconds
Assessed by using a stop watch and entering data into a questionnaire
Size of biopsies
Planimetry
Quality of biopsies
artefact-free biopsies
Exacerbation rate
Assessment of exacerbations until 4 weeks after biopsy

Full Information

First Posted
June 22, 2020
Last Updated
October 9, 2020
Sponsor
Thoraxklinik-Heidelberg gGmbH
Collaborators
Erbe Elektromedizin GmbH
search

1. Study Identification

Unique Protocol Identification Number
NCT04471324
Brief Title
EBUS Guided Cryobiopsies With Ultrathin Cryoprobe in Patients With Peripheral Pulmonary Nodules - a Feasibility Study
Official Title
EBUS Guided Cryobiopsies With Ultrathin Cryoprobe in Patients With Peripheral Pulmonary Nodules - a Feasibility Study
Study Type
Interventional

2. Study Status

Record Verification Date
October 2020
Overall Recruitment Status
Completed
Study Start Date
March 31, 2020 (Actual)
Primary Completion Date
August 31, 2020 (Actual)
Study Completion Date
August 31, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Thoraxklinik-Heidelberg gGmbH
Collaborators
Erbe Elektromedizin GmbH

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The standard procedure in the diagnosis of peripheral round foci is bronchoscopy with transbronchial forceps biopsy (TBB). Despite the simultaneous application of X-ray fluoroscopy, the diagnostic value of this method depends strongly on the size, location and relationship of the foci to the airways as well as their radiological representability. By inserting radial 20 MHz ultrasound probes through the working channel of a flexible bronchoscope into the periphery of the lung, the detection of peripheral foci can be improved. By simultaneously using a virtual bronchoscopy with an ultra-thin bronchoscope, even smaller round foci in the periphery of the lung can be detected. For some years now, tension-resistant cryoprobes have been used for transbronchial biopsy. Here, especially in lesions that can only be reached endoscopically tangentially, advantages have been shown over forceps biopsy. Much larger tissue samples can be obtained without increasing the complication rate. Studies showed that the combination of the EBUS navigation technique with the cryobiopsy procedure is feasible and safe in the endoscopic diagnosis of peripheral lung tumors. This study investigates to what extent the combination of an ultra-thin cryoprobe with an ultra-thin bronchoscope together with the radial EBUS can further improve the diagnosis. This study is a non-randomized pilot study to prove the feasibility of this procedure. The EBUS probe and the bronchoscope are CE certified for this application. The study will be conducted as a monocentric study at the Thorax Clinic at Heidelberg University Hospital. A total of 30 patients with an indication for transbronchial biopsy will be prospectively included. All patients will be examined according to the clinical standard. After a freezing time of 3-7 seconds, the probe together with the bronchoscope will be extracted and the sample will be defrosted in a water-filled sample vial. Up to 4 biopsies will be taken depending on the investigator's assessment. The samples will be collected separately and the order of the biopsies will be recorded. The primary endpoint is the feasibility of the procedure. Secondary endpoints are safety, diagnostic hit rate, biopsy size and quality and success rate depending on the position of the EBUS probe (tangential or central).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Transbronchial Cryobiopsy

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
34 (Actual)

8. Arms, Groups, and Interventions

Arm Title
EBUS cryo probe
Arm Type
Experimental
Arm Description
Patients receive a transbronchial cryobiopsy using an eBUS cryo probe
Intervention Type
Device
Intervention Name(s)
EBUS cryo probe
Intervention Description
patients receive a transbronchial cryo biopsy with the EBUS cryo probe from ERBE and an ultra thin bronchoskope
Primary Outcome Measure Information:
Title
Feasibility of the procedure - assessed by diagnosis agreement within the multidisciplinary team discussion
Description
Pathological assessment of biopsies for ILD diagnosis
Time Frame
Day 1
Secondary Outcome Measure Information:
Title
Bleeding time in seconds
Description
Assessed by using a stop watch and entering data into a questionnaire
Time Frame
Day 1 until Day 2
Title
Size of biopsies
Description
Planimetry
Time Frame
Day 1
Title
Quality of biopsies
Description
artefact-free biopsies
Time Frame
Day 1
Title
Exacerbation rate
Description
Assessment of exacerbations until 4 weeks after biopsy
Time Frame
4 weeks after biopsy

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Single or multiple peripheral pulmonary round foci in CT signed patient information Exclusion Criteria: severe co-mornidity no signed patien information contraindication for intervention
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ralf Eberhardt, Prof. Dr. med.
Organizational Affiliation
Thoraxklinik Universitaetsklinikum Heidelberg
Official's Role
Principal Investigator
Facility Information:
Facility Name
Thoraxklinik Universitaetsmedizin
City
Heidelberg
State/Province
Baden-Wuerttemberg
ZIP/Postal Code
69126
Country
Germany

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

EBUS Guided Cryobiopsies With Ultrathin Cryoprobe in Patients With Peripheral Pulmonary Nodules - a Feasibility Study

We'll reach out to this number within 24 hrs